-Of the treatments currently being developed (in reference to the list on lifespan.io), is it likely that treatments for multiple hallmarks can be used in parallel?
--Are there currently any observed or expected interactions between different treatments?
--Has any effort been made to see if the effects of multiple treatment are additive, in terms of improved lifespan, in a pre-clinical study?
-What side effects have been observed for the treatments currently in clinical trials?
It’s interesting to know that recurring and more frequent treatments are going to be needed. That point hasn’t been obvious to me before, but it could be important to consider in relation to the economics of scaling up mass anti-aging treatment—it’s not like a one of vaccination against a specific type of ageing damage, but still a ‘condition’ that requires ongoing, and perhaps increasing, care.
You are correct. I will also add a question about how much time he estimates will need to pass between one treatment and its repetition. This could be fairly calculable from the informations the scientific community already has (the rate of damage in the elderly). I will get back to you with another reply in case I come up with other questions in light of your comment and if I modify or add something to your questions.
Sure, I think the key questions would be:
-Of the treatments currently being developed (in reference to the list on lifespan.io), is it likely that treatments for multiple hallmarks can be used in parallel?
--Are there currently any observed or expected interactions between different treatments?
--Has any effort been made to see if the effects of multiple treatment are additive, in terms of improved lifespan, in a pre-clinical study?
-What side effects have been observed for the treatments currently in clinical trials?
It’s interesting to know that recurring and more frequent treatments are going to be needed. That point hasn’t been obvious to me before, but it could be important to consider in relation to the economics of scaling up mass anti-aging treatment—it’s not like a one of vaccination against a specific type of ageing damage, but still a ‘condition’ that requires ongoing, and perhaps increasing, care.
You are correct. I will also add a question about how much time he estimates will need to pass between one treatment and its repetition. This could be fairly calculable from the informations the scientific community already has (the rate of damage in the elderly). I will get back to you with another reply in case I come up with other questions in light of your comment and if I modify or add something to your questions.